Literature DB >> 12204564

Crystal habit and tableting behavior.

Norbert Rasenack1, Bernd W Müller.   

Abstract

The tableting behavior of drugs can be affected by changes in the crystal habit. Different crystal habits of the common analgesic drugs ibuprofen and acetaminophen were prepared. Their tableting behavior was characterized. In the case of ibuprofen, a plate-shaped crystal was compared with the common needle-shaped form. In the case of acetaminophen, plate-shaped and prismatic crystals of two different particle sizes were prepared. The aim was to find a crystal form that is suitable for direct compression with only a low amount of excipients. This requires a substance that forms stable compacts at low punch forces, having a good flowability and only a low tendency to stick to the punches. In order to compare the tableting behavior of different substances, a comparative factor (T-factor) was calculated, based on typical parts of the punch force/displacement-profile and properties of the resulting compact. This method works with low amounts of substance and allows a rapid reproducible determination of the tableting behavior. The method was evaluated by characterizing different typical excipients normally used for the production of tablets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204564     DOI: 10.1016/s0378-5173(02)00296-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Evidence for a new crystalline phase of racemic Ibuprofen.

Authors:  Emeline Dudognon; Florence Danède; Marc Descamps; Natália T Correia
Journal:  Pharm Res       Date:  2008-06-18       Impact factor: 4.200

2.  Study of particle rearrangement, compression behavior and dissolution properties after melt dispersion of ibuprofen, Avicel and Aerosil.

Authors:  Subrata Mallick; Saroj Kumar Pradhan; Muronia Chandran; Manoj Acharya; Tanmayee Digdarsini; Rajaram Mohapatra
Journal:  Results Pharma Sci       Date:  2011-05-17

3.  Use of first derivative of displacement vs. force profiles to determine deformation behavior of compressed powders.

Authors:  Shadi F Gharaibeh; Aktham Aburub
Journal:  AAPS PharmSciTech       Date:  2013-01-24       Impact factor: 3.246

4.  Effect of milling on particle shape and surface energy heterogeneity of needle-shaped crystals.

Authors:  Raimundo Ho; Majid Naderi; Jerry Y Y Heng; Daryl R Williams; Frank Thielmann; Peter Bouza; Adam R Keith; Greg Thiele; Daniel J Burnett
Journal:  Pharm Res       Date:  2012-08-08       Impact factor: 4.200

5.  Decoupling the contribution of surface energy and surface area on the cohesion of pharmaceutical powders.

Authors:  Umang V Shah; Dolapo Olusanmi; Ajit S Narang; Munir A Hussain; Michael J Tobyn; Steve J Hinder; Jerry Y Y Heng
Journal:  Pharm Res       Date:  2014-07-19       Impact factor: 4.200

6.  Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.

Authors:  Donatella Perrone; Maria Pia Fuggetta; Fatima Ardito; Andrea Cottarelli; Anna De Filippis; Giampietro Ravagnan; Salvatore De Maria; Lorenzo Lo Muzio
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

7.  Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.

Authors:  Maryam Maghsoodi; Farhad Kiafar
Journal:  Iran J Basic Med Sci       Date:  2013-04       Impact factor: 2.699

8.  Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.

Authors:  Maryam Maghsoodi; Farhad Kiafar
Journal:  Iran J Basic Med Sci       Date:  2013-04       Impact factor: 2.699

9.  Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.

Authors:  Kevin Garala; Jaydeep Patel; Anjali Patel; Mihir Raval; Abhay Dharamsi
Journal:  Int J Pharm Investig       Date:  2012-10

10.  Hopper Growth of Salt Crystals.

Authors:  Julie Desarnaud; Hannelore Derluyn; Jan Carmeliet; Daniel Bonn; Noushine Shahidzadeh
Journal:  J Phys Chem Lett       Date:  2018-05-21       Impact factor: 6.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.